Advertisement
Advertisement
Zemiglo

Zemiglo

Manufacturer:

GXI

Distributor:

Metro Drug
Concise Prescribing Info
Contents
Gemigliptin tartrate sesquihydrate
Indications/Uses
Adjunct to diet & exercise in adults w/ type 2 DM as monotherapy or in combination w/ metformin as initial therapy in treatment-naive patients w/ inadequate glycaemic control by diet & exercise alone, or in patients w/ inadequate glycaemic control w/ max tolerated dose of metformin alone or as triple combination w/ metformin & sulfonylurea in patients w/ inadequate glycaemic control w/ max tolerated dose of metformin & sulfonylurea dual therapy.
Dosage/Direction for Use
Max daily dose of 50 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Type 1 diabetes or diabetic ketoacidosis.
Special Precautions
Not recommended in patients w/ NYHA Class II-IV cardiac status; history of pancreatitis; risk of hypoglycaemia; severe & disabling arthralgia; concomitant use w/ sulfonylurea. Contains sunset yellow FCF. Hepatic impairment. Pregnancy & lactation. Childn <18 yr. Elderly.
Adverse Reactions
Drug Interactions
Decreased Cmax of metformin. Decreased Cmax & AUC of pioglitazone. Increased AUC w/ ketoconazole. Decreased Cmax & AUC w/ rifampicin. Hypoglycaemia w/ sulfonylurea.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BH06 - gemigliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Zemiglo FC tab 50 mg
Packing/Price
28's (P45.15/film-coated tab)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement